Nurix Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NRIX and other ETFs, options, and stocks.About NRIX
Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in the business of discovering, developing, and commercializing innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases.
CEOArthur T. Sands
CEOArthur T. Sands
Employees286
Employees286
HeadquartersSan Francisco, California
HeadquartersSan Francisco, California
Founded2009
Founded2009
Employees286
Employees286
NRIX Key Statistics
Market cap1.83B
Market cap1.83B
Price-Earnings ratio-6.08
Price-Earnings ratio-6.08
Dividend yield—
Dividend yield—
Average volume1.75M
Average volume1.75M
High today$18.26
High today$18.26
Low today$16.50
Low today$16.50
Open price$16.83
Open price$16.83
Volume1.56M
Volume1.56M
52 Week high$22.95
52 Week high$22.95
52 Week low$8.18
52 Week low$8.18
Stock Snapshot
With a market cap of 1.83B, Nurix Therapeutics(NRIX) trades at $18.26. The stock has a price-to-earnings ratio of -6.08.
During the trading session on 2025-12-04, Nurix Therapeutics(NRIX) shares reached a daily high of $18.26 and a low of $16.50. At a current price of $18.26, the stock is +10.7% higher than the low and still 0.0% under the high.
Trading volume for Nurix Therapeutics(NRIX) stock has reached 1.56M, versus its average volume of 1.75M.
Over the past 52 weeks, Nurix Therapeutics(NRIX) stock has traded between a high of $22.95 and a low of $8.18.
Over the past 52 weeks, Nurix Therapeutics(NRIX) stock has traded between a high of $22.95 and a low of $8.18.
Analyst ratings
94%
of 17 ratingsBuy
94.1%
Hold
5.9%
Sell
0%
People also own
Based on the portfolios of people who own NRIX. This list is generated using Robinhood data, and it’s not a recommendation.